Dabur India Q4 FY26 Earnings Call Transcript Released
Dabur India released its Q4 FY26 earnings call transcript from May 7, 2026. Consolidated revenue grew 7.3% YoY, with domestic FMCG up 9.5%. HPC portfolio grew 17%, driven by strong performance in Hair Care, Home Care, and Skin Care. Healthcare and Beverages also showed positive growth. Management expects sequential growth acceleration in FY27, targeting high single to low double-digit revenue growth.
The announcement is a transcript of an earnings call, providing detailed financial performance and future outlook. While positive, it doesn't introduce new major strategic shifts or significant financial events that would warrant a 'HIGH' impact. It serves as an important update for investors.
The company reported positive year-on-year growth in consolidated revenue and PAT, with strong performance across key portfolios like HPC and beverages. Management expressed confidence in future growth and margin expansion.
Dabur India Limited has released the transcript of its investors' conference call held on May 07, 2026, following the declaration of financial results for the quarter and financial year ended March 31, 2026. The call featured insights from Global CEO Mohit Malhotra, CFO Ankush Jain, and other key management.
During the call, management discussed steady demand conditions in India, with rural markets outperforming urban areas, though the gap has narrowed. Geopolitical headwinds in the Middle East are impacting input costs and supply chains.
Consolidated revenue grew by 7.3% year-on-year in Q4, with domestic FMCG business up 9.5% (6% volume growth). The HPC portfolio showed strong double-digit growth (17%), driven by Hair Care (28%), Home Care (24%), and Skin Care. Toothpaste grew 7.2%, and the herbal segment outperformed.
In healthcare, the digestive portfolio grew in mid-teens, while health supplements like Honey saw strong growth (over 20%). Beverages showed sequential recovery, with Real Activ Juices up 26% and Coconut Water up 100%. Culinary business grew 30%. International business reported muted growth of 2.5% in INR terms.
Consolidated operating profit grew 8.2%, and PAT grew 15%. Management expressed confidence in sequential acceleration of India business growth, driven by stable consumption, go-to-market transformation, premiumization, and brand building.
Discussions also covered inflation, with management indicating a ~10% inflation impact across portfolios and implementing a 4% price increase. Future outlook suggests a high single to low double-digit revenue growth for FY27, with a mix of volume and pricing. Margin expansion is targeted through price increases, cost savings, and premiumization, with a priority on protecting margins over media spend during high inflation periods.
What to do with a filing like this
Dabur India Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Dabur India Limited. Read the original for the full detail.